These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10782483)

  • 1. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV).
    Vynograd N; Vynograd I; Sosnowski Z
    Phytomedicine; 2000 Mar; 7(1):1-6. PubMed ID: 10782483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
    Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA
    J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of herpes simplex virus type 2 suppression by propolis extracts.
    Nolkemper S; Reichling J; Sensch KH; Schnitzler P
    Phytomedicine; 2010 Feb; 17(2):132-8. PubMed ID: 19682876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
    N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acyclovir creme in recurrent herpes genitalis].
    Laerum E; Gabrielsen BO; Halsos A; Johnson M; Moseng D; Helland S; Slørdahl M
    Tidsskr Nor Laegeforen; 1989 Mar; 109(7-8):847-9. PubMed ID: 2650015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
    Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
    N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Benedetti JK; Critchlow CW; Remington MR; Winter CA; Fahnlander AL; Smith K; Salter DL; Keeney RE; Davis LG; Hintz MA; Connor JD; Holmes KK
    Am J Med; 1982 Jul; 73(1A):326-34. PubMed ID: 7048919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA; Trottier S; Miller JM
    Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
    Al-Waili NS
    Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.
    Tyring S; Wald A; Zadeikis N; Dhadda S; Takenouchi K; Rorig R
    J Infect Dis; 2012 Apr; 205(7):1100-10. PubMed ID: 22351940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.